Contraindications include personal/family history of medullary thyroid cancer, multiple endocrine neoplasia type 2, and severe kidney or liver disease
Kornelius, E., Huang, J
Tirzepatide Injections: Clinical Evidence on Hair Safety The Phase 3 SURMOUNT trials, which tested tirzepatide injections in over 2,500 adults with obesity, reported hair loss in fewer than 2% of participants as a treatment-related adverse event
For patients receiving selenium supplementation, periodic serum selenium or GPx activity may be informative in research settings (259)
Datroway is FDA-approved for: Hormone receptorpositive, HER2-negative advanced breast cancer, including HER2-low tumors, in adults whove had prior hormone therapy and chemotherapy
In Vitro Observations on the Influence of Copper Peptide on fibroblast proliferation and collagen production